KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Current Taxes (2016 - 2025)

Historic Current Taxes for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $2.0 billion.

  • Novartis Ag's Current Taxes rose 2313.95% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 2313.95%. This contributed to the annual value of $2.0 billion for FY2025, which is 2313.95% up from last year.
  • Latest data reveals that Novartis Ag reported Current Taxes of $2.0 billion as of Q4 2025, which was up 2313.95% from $3.3 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Current Taxes registered a high of $3.3 billion during Q3 2025, and its lowest value of $1.6 billion during Q4 2024.
  • Its 5-year average for Current Taxes is $2.4 billion, with a median of $2.4 billion in 2021.
  • As far as peak fluctuations go, Novartis Ag's Current Taxes surged by 37284.23% in 2021, and later tumbled by 4436.95% in 2024.
  • Novartis Ag's Current Taxes (Quarter) stood at $2.4 billion in 2021, then grew by 4.89% to $2.5 billion in 2022, then dropped by 25.27% to $1.9 billion in 2023, then dropped by 15.53% to $1.6 billion in 2024, then rose by 23.14% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q4 2025, $3.3 billion for Q3 2025, and $2.8 billion during Q2 2025.